BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8175970)

  • 1. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction.
    Canale MP; Bravo EL
    J Clin Endocrinol Metab; 1994 May; 78(5):1139-44. PubMed ID: 8175970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significant of serum chromogranin A levels for diagnosing pheochromocytoma in hypertensive patients].
    Biausque F; Jaboureck O; Devos P; D'Herbomez M; Hainaut P; Carré A; Mounier-Vehier C
    Arch Mal Coeur Vaiss; 2003; 96(7-8):780-3. PubMed ID: 12945223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
    Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
    Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
    d'Herbomez M; Gouze V; Huglo D; Nocaudie M; Pattou F; Proye C; Wémeau JL; Marchandise X
    J Nucl Med; 2001 Jul; 42(7):993-7. PubMed ID: 11438617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
    Giovanella L
    Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
    Giovanella L; Ceriani L
    Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
    Giovanella L; Squin N; Ghelfo A; Ceriani L
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the biochemical diagnosis of 66 pheochromocytomas.
    d'Herbomez M; Forzy G; Bauters C; Tierny C; Pigny P; Carnaille B; Pattou F; Wémeau JL; Rouaix N
    Eur J Endocrinol; 2007 May; 156(5):569-75. PubMed ID: 17468193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
    Stridsberg M; Husebye ES
    Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
    Giovanella L; Ceriani L; Balerna M; Keller F; Taborelli M; Marone C; Ferone D
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):84-88. PubMed ID: 17538521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
    Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
    Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
    Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
    Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pheochromocytoma: different patterns of catecholamines and chromogranins in the intact tumour, urine and serum in clinically unsuspected cases.
    Aardal S; Aardal NP; Larsen TH; Angeletti RH; Stridsberg M; Taupenot L; Aunis D; Helle KB
    Scand J Clin Lab Invest; 1996 Oct; 56(6):511-23. PubMed ID: 8903113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma: state-of-the-art and future prospects.
    Bravo EL; Tagle R
    Endocr Rev; 2003 Aug; 24(4):539-53. PubMed ID: 12920154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis.
    Kailasam MT; Parmer RJ; Stone RA; Shankel S; Kennedy BP; Ziegler MG; O'Connor DT
    Am J Hypertens; 1995 Jun; 8(6):651-5. PubMed ID: 7662252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma.
    Boomsma F; Bhaggoe UM; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1995 Jul; 239(1):57-63. PubMed ID: 7586587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
    Gröndal S; Eriksson B; Hamberger B; Theodorsson E
    J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
    Rao F; Keiser HR; O'Connor DT
    Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chromogranin A in the management of patients with phaeochromocytoma.
    Grossrubatscher E; Dalino P; Vignati F; Gambacorta M; Pugliese R; Boniardi M; Rossetti O; Marocchi A; Bertuzzi M; Loli P
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):287-93. PubMed ID: 16918946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.